Latent human herpesvirus 6 is reactivated in CAR T cells
Caleb A. Lareau, Yajie Yin, Katie Maurer, Katalin Sándor, Bence Dániel, Garima Yagnik, José Peña, Jeremy Chase Crawford, Anne M. Spanjaart, Jacob C. Gutierrez, Nicholas J. Haradhvala, Janice M. Riberdy, Tsion Abay, Robert R. Stickels, Jeffrey M. Verboon, Vincent Liu, Frank A. Buquicchio, Fangyi Wang, Jackson Southard, Song Ren, Wenjing Li, Aastha Shrestha, Laxmi Parida, Gad Getz, Marcela V. Maus, Shuqiang Li, Alison Moore, Zachary Roberts, Leif S. Ludwig, Aimee C. Talleur, Paul G. Thomas, Houman Dehghani, Thomas Pertel, Anshul Kundaje, Stephen Gottschalk, Theodore L. Roth, Marie José Kersten, Catherine J. Wu, Robbie G. Majzner, Ansuman T. Satpathy
Topics & Concepts
Chimeric antigen receptorLytic cycleHuman herpesvirus 6PopulationCellImmunologyBiologyClinical trialCell therapyVirologyMedicineT cellVirusBioinformaticsHerpesviridaeGeneticsViral diseaseImmune systemEnvironmental healthCytomegalovirus and herpesvirus researchCAR-T cell therapy researchImmune Cell Function and Interaction